15 Einträge gefunden

1. Chromosome 5 harbors two independent deletion hotspots at 5q13 and 5q21 that characterize biologically different subsets of aggressive prostate cancer

   1. Möller, Katharina
   2. Kluth, Martina
   3. Ahmed, Malik
   4. Burkhardt, Lia
   5. Möller-Koop, Christina
   6. Büscheck, Franziska
   7. Weidemann, Sören

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical Recurrence

   1. Kind, Simon
   2. Kluth, Martina
   3. Hube-Magg, Claudia
   4. Möller, Katharina
   5. Makrypidi-Fraune, Georgia
   6. Lutz, Florian
   7. Lennartz, Maximilian

   2020 - Forschungsinformationssystem des UKE
3. Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer

   1. Freytag, Morton
   2. Kluth, Martina
   3. Bady, Elena
   4. Hube-Magg, Claudia
   5. Makrypidi-Fraune, Georgia
   6. Heinzer, Hans
   7. Höflmayer, Doris

   2020 - Forschungsinformationssystem des UKE
4. High B7-H3 expression is linked to increased risk of prostate cancer progression

   1. Bonk, Sarah
   2. Tasdelen, Pinar
   3. Kluth, Martina
   4. Hube-Magg, Claudia
   5. Makrypidi-Fraune, Georgia
   6. Möller, Katharina
   7. Höflmayer, Doris

   2020 - Forschungsinformationssystem des UKE
5. High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer

   1. Heumann, Asmus
   2. Heinemann, Nina
   3. Hube-Magg, Claudia
   4. Lang, Dagmar S
   5. Grupp, Katharina
   6. Kluth, Martina
   7. Minner, Sarah

   2018 - Forschungsinformationssystem des UKE - frei zugänglich
6. Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer

   1. Melling, Nathaniel
   2. Taskin, B
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Minner, Sarah
   6. Koop, Christina
   7. Grob, Tobias

   2016 - Forschungsinformationssystem des UKE
7. Heterogeneity and chronology of 6q15 deletion and ERG-fusion in prostate cancer

   1. Kluth, Martina
   2. Meyer, David
   3. Krohn, Antje
   4. Freudenthaler, Fabian
   5. Bauer, Melanie
   6. Salomon, Georg
   7. Heinzer, Hans

   2016 - Forschungsinformationssystem des UKE
8. Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers

   1. Burdelski, Christoph
   2. Kleinhans, Sandra
   3. Kluth, Martina
   4. Hube-Magg, Claudia
   5. Minner, Sarah
   6. Koop, Christina
   7. Graefen, Markus

   2016 - Forschungsinformationssystem des UKE
9. Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer

   1. Burdelski, Christoph
   2. Reiswich, V.
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Minner, Sarah
   6. Koop, Christina
   7. Graefen, Markus

   2015 - Forschungsinformationssystem des UKE
10. The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion

    1. Burdelski, Christoph
    2. Menan, Devi
    3. Tsourlakis, Maria Christina
    4. Kluth, Martina
    5. Hube-Magg, Claudia
    6. Melling, Nathaniel
    7. Minner, Sarah

    2015 - Forschungsinformationssystem des UKE - frei zugänglich
11. VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomy

    1. Tsourlakis, Maria Christina
    2. Khosrawi, Puya
    3. Weigand, Philipp
    4. Kluth, Martina
    5. Hube-Magg, Claudia
    6. Minner, Sarah
    7. Koop, Christina

    2015 - Forschungsinformationssystem des UKE - frei zugänglich
12. Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers

    1. Burdelski, Christoph
    2. Bujupi, Erzen
    3. Tsourlakis, Maria Christina
    4. Hube-Magg, Claudia
    5. Kluth, Martina
    6. Melling, Nathaniel
    7. Lebok, Patrick

    2015 - Forschungsinformationssystem des UKE - frei zugänglich
13. Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer

    1. Burdelski, Christoph
    2. Strauss, Christian
    3. Tsourlakis, Maria Christina
    4. Kluth, Martina
    5. Hube-Magg, Claudia
    6. Melling, Nathaniel
    7. Lebok, Patrick

    2015 - Forschungsinformationssystem des UKE
14. Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters

    1. Melling, Nathaniel
    2. Thomsen, Erik
    3. Tsourlakis, Maria Christina
    4. Kluth, Martina
    5. Hube-Magg, Claudia
    6. Minner, Sarah
    7. Koop, Christina

    2015 - Forschungsinformationssystem des UKE
15. Marked heterogeneity of ERG expression in large primary prostate cancers.

    1. Minner, Sarah
    2. Gärtner, Michael
    3. Freudenthaler, Fabian
    4. Bauer, Melanie
    5. Kluth, Martina
    6. Salomon, Georg
    7. Heinzer, Hans

    2013 - Forschungsinformationssystem des UKE